This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches
- Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches
- Role of Positron Emission Tomography in Lymphoma
- Intensity of 18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin's Lymphoma
- Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
- Prognostic Value of PET Using 18F-FDG in Hodgkin's Disease for Posttreatment Evaluation
- Overview of clinical PET
- Challenging Cases and Diagnostic Dilemmas: Case 2. Pitfalls of Positron Emission Tomography for Assessing Residual Mediastinal Mass After Chemotherapy for Hodgkin's Disease
- PET Predicts Prognosis After 1 Cycle of Chemotherapy in Aggressive Lymphoma and Hodgkin's Disease
- Clinical Applications of 18F-FDG in Oncology
- Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
- Whole body applications of positron emission tomography in oncology
- Effect of Whole-Body 18F-FDG PET Imaging on Clinical Staging and Management of Patients with Malignant Lymphoma
- Impact of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography on Patient Management: First Year's Experience in a Clinical Center
- A Tabulated Summary of the FDG PET Literature
- Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin's Lymphoma
- FDG PET Imaging in Patients with Lymphoma: A Clinical Perspective
- Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin's Lymphomas
- Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([18F]FDG) After First-Line Chemotherapy in Non-Hodgkin's Lymphoma: Is [18F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?
- Nodal Staging of Lymphoma with Whole-Body PET: Comparison of [11C]Methionine and FDG
- Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography